Treatment-Related Adverse Events, Including Fatal Toxicities, in Patients with Extensive-Stage Small Cell Lung Cancer Receiving Adjuvant PD-1/PD-L1 Inhibitors: a Meta-Analysis and Trial Sequential Analysis of Randomized Controlled Trials
Article in Clinical Oncology (July 2024)